Glucotrack Reports Q2 GAAP EPS of -$9.62, Cash and Cash Equivalents at $9.6M

Friday, Aug 15, 2025 6:22 am ET1min read

Glucotrack reported Q2 GAAP EPS of -$9.62, with cash and cash equivalents at $9.6 million as of June 30, 2025, compared to $5.6 million as of December 31, 2024.

Glucotrack Reports Q2 GAAP EPS of -$9.62, Cash and Cash Equivalents at $9.6M

Comments



Add a public comment...
No comments

No comments yet